QGENQIAGEN N.V.

NYSE qiagen.com


$ 42.34 $ -1.01 (-2.33 %)    

Friday, 14-Jun-2024 15:59:56 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 42.34
$ 43.10
$ 0.00 x 0
$ 0.00 x 0
$ 42.28 - $ 43.10
$ 33.76 - $ 46.35
898,392
na
9.66B
$ 0.66
$ 28.31
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 qiagen-launches-digital-pcr-assay-design-tool-for-qiacuity-expands-customization-capabilities-of-its-research-platform-geneglobe

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the launch of its new digital PCR (dPCR) Custom Assay Desi...

 qiagen-launches-rapid-gi-infection-test-in-the-us-approved-by-fda

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in t...

 qualigen-therapeutics-received-nasdaq-notice-of-a-delisting-determination

Qualigen Therapeutics, Inc. (("Qualigen" or "the Company, NASDAQ:QLGN), announced today that on May 23, 2024, it re...

 qiagen-secures-european-ivdr-certification-for-qiagen-clinical-insight-interpret-its-clinical-decision-support-software

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced an updated version of its clinical decision support platfo...

 fda-clears-qiagens-qiastat-dx-respiratory-syndromic-testing-panel-for-fast-and-accurate-results

The QIAstat-Dx Respiratory Panel Plus is designed to support clinical decision-making in diagnosing upper respiratory infection...

 qiagen-partners-with-fbi-to-develop-digital-pcr-assay-for-qiacuity-for-use-in-forensics

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced a cooperative research and development agreement (CRADA) w...

 will-earnings-cheer-continue-this-week-all-eyes-on-disney-palantir-robinhood-while-reddit-gears-up-for-debut-quarterly-report

According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.

 qiagen-enhances-bioinformatics-workflows-with-new-secondary-analysis-solution-for-oncology-and-inherited-disease-applications

QIAGEN  (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the availability of QCI Secondary Analysis, a cloud-based...

 stifel-maintains-hold-on-qiagen-lowers-price-target-to-45

Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target from $55 to $45.

 qiagen-q1-2024-adj-eps-046-beats-044-estimate-sales-458796m-beat-457330m-estimate

Qiagen (NYSE:QGEN) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.44 by 4.55 pe...

 us-stocks-kick-off-the-week-in-the-green-tesla-rockets-on-chinas-fsd-approval-yen-rallies-whats-driving-markets-monday

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...

 us-stocks-set-to-approach-new-week-with-caution-ahead-of-fed-meeting-tech-earnings-analyst-says-buy-the-dip-contingent-on-this-condition

U.S. stocks are looking to build on past week’s gains, with the mood remaining cautiously optimistic. The major index futures w...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 qiagen-expands-tuberculosis-portfolio-with-new-ngs-panel-to-support-real-time-surveillance-and-combat-antimicrobial-resistance

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the launch of the QIAseq xHYB Mycobacterium tuberculosis P...